IL151370A0 - An antibody that binds to ecrtp/dep-1 and pharmaceutical compositions containing an ecrtp/dep-1 polypeptide or amide - Google Patents

An antibody that binds to ecrtp/dep-1 and pharmaceutical compositions containing an ecrtp/dep-1 polypeptide or amide

Info

Publication number
IL151370A0
IL151370A0 IL15137001A IL15137001A IL151370A0 IL 151370 A0 IL151370 A0 IL 151370A0 IL 15137001 A IL15137001 A IL 15137001A IL 15137001 A IL15137001 A IL 15137001A IL 151370 A0 IL151370 A0 IL 151370A0
Authority
IL
Israel
Prior art keywords
ecrtp
dep
polypeptide
binds
antibody
Prior art date
Application number
IL15137001A
Original Assignee
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/516,728 external-priority patent/US7176289B1/en
Application filed by Univ Vanderbilt filed Critical Univ Vanderbilt
Publication of IL151370A0 publication Critical patent/IL151370A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL15137001A 2000-03-01 2001-02-27 An antibody that binds to ecrtp/dep-1 and pharmaceutical compositions containing an ecrtp/dep-1 polypeptide or amide IL151370A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/516,728 US7176289B1 (en) 1998-09-11 2000-03-01 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
PCT/US2001/006178 WO2001064750A2 (en) 2000-03-01 2001-02-27 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis

Publications (1)

Publication Number Publication Date
IL151370A0 true IL151370A0 (en) 2003-04-10

Family

ID=24056849

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15137001A IL151370A0 (en) 2000-03-01 2001-02-27 An antibody that binds to ecrtp/dep-1 and pharmaceutical compositions containing an ecrtp/dep-1 polypeptide or amide
IL151370A IL151370A (en) 2000-03-01 2002-08-21 Antibody that binds to an eight amino acid epitope and pharmaceutical compositions containing the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL151370A IL151370A (en) 2000-03-01 2002-08-21 Antibody that binds to an eight amino acid epitope and pharmaceutical compositions containing the same

Country Status (7)

Country Link
EP (1) EP1261644A2 (en)
JP (1) JP2004507210A (en)
AU (1) AU3989801A (en)
CA (1) CA2401621A1 (en)
IL (2) IL151370A0 (en)
MX (1) MXPA02008462A (en)
WO (1) WO2001064750A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004048549A2 (en) * 2002-11-26 2004-06-10 Cold Spring Harbor Laboratory Dep-1 receptor protein tyrosine phosphatase interacting proteins and related methods
EP1751191A2 (en) * 2004-04-23 2007-02-14 Amgen Inc. Antibodies to angiogenesis inhibiting domains of cd148
AU2005249381A1 (en) * 2004-04-23 2005-12-15 Amgen Inc. Antibodies of angiogenesis inhibiting domains of CD148
US11723926B2 (en) 2019-09-27 2023-08-15 Starkage Therapeutics Senescent cell-associated antigen-binding domains, antibodies and chimeric antigen receptors comprising the same, and uses thereof
EP4034561A2 (en) * 2019-09-27 2022-08-03 Starkage Therapeutics Senescent cell-associated antigen-binding domains, antibodies and chimeric antigen receptors comprising the same, and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0708831T4 (en) * 1994-05-03 2008-04-14 Cold Spring Harbor Lab Cell density-enhanced protein tyrosine phosphatases
US6248327B1 (en) * 1998-09-11 2001-06-19 Vanderbilt University Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis

Also Published As

Publication number Publication date
IL151370A (en) 2010-11-30
MXPA02008462A (en) 2004-05-14
EP1261644A2 (en) 2002-12-04
JP2004507210A (en) 2004-03-11
WO2001064750A3 (en) 2002-01-24
CA2401621A1 (en) 2001-09-07
WO2001064750A2 (en) 2001-09-07
AU3989801A (en) 2001-09-12

Similar Documents

Publication Publication Date Title
HUP0500880A2 (en) Cxcr3 antagonists and pharmaceutical compositions thereof
HUP0400974A3 (en) Peptide-based compounds and pharmaceutical compositions containing them
IL200608A0 (en) Methods for the detection of 193p1e1b protein and use of compositions containing a 193p1e1b protein or an antibody binding thereto
IL160001A0 (en) Peptide based multimeric targeted contrast agents and methods for the preparation thereof
IL155284A0 (en) Fused ring compounds and pharmaceutical compositions containing the same
IL162547A0 (en) Fused heterocyclic succinimide derivatives and pharmaceutical compositions containing the same
HUP0400245A3 (en) Somatostatin-dopamine chimeric analogs and pharmaceutical compositions containing them
IL158297A0 (en) Pharmaceutical compositions containing immune globulin and methods for the preparation thereof
HUP0401733A3 (en) Cyclic amine-derivatives and pharmaceutical compositions containing them
IL170080A (en) Nucleic acid and protein named 158p1d7 and pharmaceutical compositions containing the same
EP1171152A4 (en) vMIP-II PEPTIDE ANTAGONISTS OF CXCR4
HUP0400976A3 (en) Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides
HUP0303956A2 (en) Pregabalin lactose conjugates and pharmaceutical compositions containing them
IL173626A0 (en) Small peptides and oral pharmaceutical compositions containing the same
IL152202A0 (en) Human kcnq5 polypeptide and pharmaceutical compositions containing the same
IL151370A0 (en) An antibody that binds to ecrtp/dep-1 and pharmaceutical compositions containing an ecrtp/dep-1 polypeptide or amide
IL158293A0 (en) Nucleic acid and corresponding protein entitled 158p3d2 and pharmaceutical compositions containing the same
IL156711A0 (en) Peptide derivatives and pharmaceutical compositions containing the same
IL161544A0 (en) Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides
EP1360964A4 (en) Use of galanin-like peptide
IL160651A0 (en) Nucleic acid and correspondidng protein entitled 205pib5 and pharmaceutical compositions containing the same
IL135442A0 (en) Peptides and pharmaceutical compositions comprising them
HUP0500956A3 (en) Oxapenem-3-carboxylic acids and pharmaceutical compositions containing them
HUP0401312A3 (en) Peptide arginals and pharmaceutical compositions containing such compounds
GB0014209D0 (en) Protein and compositions containing it